Research
Energy balance
Patients experienced an average weight loss of 16.06 ± 7.6 pounds at 12 weeks and 38.82 ± 11.4 pounds at 24 weeks.
Practitioners can expect significant weight loss in patients using compounded GLP-1 ± GIP agonists.
StrongSupportsmedium confidence
The average weight loss observed at 12 weeks was 16.06 ± 7.6 pounds ( p = 0.001) and 38.82 ± 11.4 pounds at 24 weeks.
Why this rating
Based on the retrospective cohort study design with a clear outcome measure.
Source
Real‐world observations of using compounded <scp>GLP</scp> ‐1 ± <scp>GIP</scp> agonists within a clinical pharmacist‐managed cardiometabolic clinic
Shannon W. Finks et al. · JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY · 2025
DOI 10.1002/jac5.2071
cohort · n=50Cited 2×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Energy balance
- Achieving a total body weight loss of 10-15% (or >10-15 kg) through Total Diet Replacement (TDR) induces remission of Type 2 Diabetes in individuals with short-duration disease.Strong
- Bariatric surgery is superior to medical management alone for inducing significant long-term weight loss, remission of type 2 diabetes, and reduction in mortality for patients with BMI ≥ 40 or ≥ 35 with comorbidities.Strong
- Achieving type 2 diabetes remission requires significant weight loss (≥15 kg) via major caloric restriction, independent of macronutrient composition.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →